Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • seqadmin
    Senior Member
    • Oct 2022
    • 729

    #1

    More Accurate Tuberculosis Genome

    A team of researchers from Rutgers University updated the reference sequence for Mycobacterium tuberculosis strain H37Rv in a recent publication in Nature Communications.

    The previous reference sequence for M. tuberculosis, the causative agent of tuberculosis, was commonly used in research despite containing inaccuracies. Tuberculosis is a leading cause of death worldwide and causes illness for millions of people each year (World Health Organization). Therefore, the availability of an accurate reference genome was crucial for clinical and infectious disease research.

    Assembly of a complete M. tuberculosis genome was challenging due to the organism’s highly repetitive regions, which account for around 10% of the genome. These difficult regions also make an assembly using short reads much more difficult. To combat these challenges, the researchers used the MinION from Oxford Nanopore to obtain the needed long reads and polished the assembly using short reads from Illumina instruments.

    The final assembly of strain H37Rv added 6.4 kb of new sequence into the reference along with changes to 10 major regions. It also led to the development of Bact-Builder, a new tool for de novo assembly of accurate bacterial genomes.

    Bact-Builder uses long reads for a consensus-based assembly and further polishes the assembly with both long and short reads. It was first designed using reads generated in silico and was then tested using actual reads from the MinION and Illumina’s NovaSeq.

    The creation of Bact-Builder can help researchers build other bacterial genomes and the changes to the H37Rv reference sequence hope to improve tuberculosis research worldwide.

    Read the original journal article here.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...